A service of arranging or bringing about contact between an investment manager and an issuer or potential issuer.
During this fireside chat we welcome Modular Medical (Nasdaq: MODD). Modular Medical is a development-stage, medical device company focused on the design, development, and commercialization of an innovative insulin pump using modernized technology to increase pump...
During this fireside chat we welcome Shuttle Pharma (Nasdaq: SHPH). Shuttle Pharma is a discovery and development stage specialty pharmaceutical company focused on improving the outcomes for cancer patients treated with radiation therapy (RT). This fireside chat was...
In this special Analyst Insights segment, Adam Lowensteiner, Vice President of Lytham Partners is joined by Allen Klee of Maxim Group for a discussion on the Healthcare IT sector. This Panel was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
During this fireside chat we welcome Aurora Spine Corporation (TSXV: ASG / OTCQB: ASAPF). Aurora Spine is an early-stage company focused on bringing new solutions to the spinal implant market through a series of screwless, innovative, minimally invasive, regenerative...
During this fireside chat we welcome VitalHub (TSX: VHI / OTCQX: VHIBF). VitalHub is a leading software company dedicated to empowering health and human services providers globally. This fireside chat was recorded during the Lytham Partners 2025 Investor Healthcare...
During this fireside chat we welcome Jaguar Health (Nasdaq: JAGX). Jaguar Health, Inc. is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and...
During this fireside chat we welcome Mesoblast Limited (Nasdaq: MESO). Mesoblast is a world leader in developing allogeneic (off-the-shelf) cellular medicines for the treatment of severe and life-threatening inflammatory conditions. This fireside chat was recorded...
During this fireside chat we welcome Cadrenal Therapeutics (Nasdaq: CVKD). Cadrenal Therapeutics is developing tecarfarin for unmet needs in anticoagulation therapy. Tecarfarin is a late-stage novel oral and reversible anticoagulant (blood thinner) to prevent heart...
During this fireside chat we welcome Aytu BioPharma (Nasdaq: AYTU). Aytu is a pharmaceutical company focused on commercializing novel therapeutics. This fireside chat was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
This company webcast features NeurAxis, Inc. (NYSE American: NRXS). NeurAxis is a medical technology company focused on neuromodulation therapies to address chronic and debilitating conditions in children and adults. This company webcast was recorded during the Lytham...
This company webcast features Quipt Home Medical (Nasdaq: QIPT / TSX: QIPT). Quipt provides in-home monitoring and disease management services including end-to-end respiratory solutions for patients in the United States healthcare market. This company webcast was...
This company webcast features PolyPid Ltd. (Nasdaq: PYPD). PolyPid is a late-stage biopharma company aiming to improve surgical outcomes. This company webcast was recorded during the Lytham Partners 2025 Investor Healthcare Summit.
This company webcast features Reviva Pharmaceuticals Holdings (Nasdaq: RVPH). Reviva is a late-stage biopharmaceutical company that discovers, develops, and seeks to commercialize next-generation therapeutics for diseases representing unmet medical needs and burdens...
This company webcast features ChromaDex Corp. (Nasdaq: CDXC). ChromaDex is the global authority on nicotinamide adenine dinucleotide (NAD+), with a focus on the science of healthy aging. This company webcast was recorded during the Lytham Partners 2025 Investor...
This company webcast features Cybin, Inc. (NYSE American: CYBN). Cybin is a late-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options to address the large unmet...
This company webcast features Beyond Air (Nasdaq: XAIR). Beyond Air is a commercial stage medical device and biopharmaceutical company dedicated to harnessing the power of endogenous and exogenous nitric oxide (NO) to improve the lives of patients suffering from...
This company webcast features Kairos Pharma (NYSE American: KAPA). Kairos Pharma is at the forefront of oncology therapeutics, utilizing structural biology to overcome drug resistance and immune suppression in cancer. This company webcast was recorded during the...
This company webcast features Genvara BioPharma. Genvara Biopharma's mission is to develop pharmacogenetically-targeted cardiovascular drugs acting through novel mechanisms of action. This company webcast was recorded during the Lytham Partners 2025 Investor...
This company webcast features Botanix Pharmaceuticals (ASX: BOT). Botanix engages in the research and development of dermatology and antimicrobial products in Australia and the United States. This company webcast was recorded during the Lytham Partners 2025 Investor...
During this fireside chat we welcome Osteogene. Osteogene Tech Corp. is dedicated to bettering the health and quality of life for people around the world with our work in the bone graft industry. This fireside chat was recorded during the Lytham Partners 2025 Investor...
During this fireside chat we welcome Unicycive Therapeutics (Nasdaq: UNCY). Unicycive Therapeutics is a biotechnology company developing novel treatments for kidney diseases. This fireside chat was recorded during the Lytham Partners 2025 Investor Healthcare Summit.